Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
It should be handled only by qualified personnel in an appropriate laboratory setting, following standard practices for research chemicals
Spotlight Drug: Ranibizumab Approved Indications: Neovascular (Wet) Age-Related Macular Degeneration (AMD) Visual Impairment Due to Diabetic Macular Oedema (DME) Why is this important Wet AMD occurs when abnormal blood vessels grow beneath the retina, leaking fluid and blood that rapidly damage central vision
Why We Picked Them: Charles Kamen, MD leads the clinical team
Slow Responders do lose weight, but at a slower pace
%20copy.jpg)
US$ 26.47
US$ 25.01
US$ 27.83
